Additionally, even in the absence of elevations in circulating estrogens, obesity is a risk factor for endometrial cancer through obesity-induced insulin resistance and the resultant higher insulin levels (46), as discussed above. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.